Downloading...
Download

Intuitivesurgical

Intuit Inc. (NASDAQ: INTU) Surges 8% on Strong Earnings BeatIntuit Inc. (NASDAQ: INTU), a leading provider of financial management, compliance, and marketing solutions, saw its stock surge 8% in premarket trading following an impressive earnings beat. The company’s strong financial performance, coupled with increasing demand for its AI-driven financial services software, has positioned NASDAQ:INTU for a potential breakout. AI Expansion and Tax Season Demand Intuit, the maker of TurboTax, QuickBooks, and Credit Karma, has been capitalizing on the growing demand for AI-powered financial solutions. The ongoing tax season in the U.S. has further boosted demand for its software, with the bulk of tax filings expected in Q3. In its latest earnings report, Intuit exceeded Wall Street expectations, reporting second-quarter revenue of $3.96 billion, surpassing the estimated $3.83 billion. Adjusted earnings per share (EPS) came in at $3.32, significantly outperforming estimates of $2.58. However, while Intuit’s Q3 revenue forecast of $7.55 billion–$7.60 billion surpassed the analyst consensus of $7.51 billion, its adjusted profit per share projection of $10.89–$10.95 fell short of the expected $11.48. Despite workforce reductions in 2024, Intuit rapidly filled vacant positions, underscoring its operational efficiency and ability to scale talent acquisition. The company's AI-powered assistant, Intuit Assist, launched in November 2024 for QuickBooks, is further streamlining tax and financial management tasks, enhancing productivity for small businesses and individuals alike. Technical Outlook As of the time of writing, NASDAQ:INTU has surged 8% in premarket trading, forming a bullish engulfing pattern. The stock had previously closed down 2.2% in the last session, trading below key moving averages (MA). However, this premarket jump places NASDAQ:INTU on the cusp of a breakout. Key technical indicators suggest room for further upside: - Relative Strength Index (RSI): Currently at 54, indicating ample room for continued bullish momentum before entering overbought territory. - Fibonacci Retracement Support: The 38.2% Fibonacci retracement level is acting as a key support zone, potentially providing a cushion against pullbacks. - Breakout Potential: A decisive move above the 1-month high could push the stock toward the 38.2% Fibonacci extension zone, paving the way for new resistance levels and a sustained bullish run.
NASDAQ:INTULong
by DEXWireNews
ISRG Down 2% in Premarket Trading Despite Beating ExpectationsIntuitive Surgical, Inc. (ISRG) experienced a 2% dip in premarket trading on Friday despite reporting robust fourth-quarter earnings that exceeded analysts’ expectations. The medical device company, known for its revolutionary da Vinci surgical robots, continues to showcase its dominance in the minimally invasive surgery market. Here’s a detailed look at the company’s performance, supported by fundamental and technical insights. Strong Financial Performance Intuitive Surgical reported a 25% year-over-year increase in fourth-quarter revenue, reaching $2.41 billion. This figure surpassed the consensus estimate compiled by Visible Alpha, reinforcing the company’s strong growth trajectory. Earnings rose to $686 million, or $1.88 per share, up from $606 million, or $1.69 per share, a year ago. These figures also beat analysts’ expectations, demonstrating the company’s profitability. Operational Highlights Procedure Growth: The number of procedures performed using da Vinci surgical devices increased by 18% year-over-year, signaling strong demand for Intuitive Surgical’s minimally invasive technology. System Installations: The company installed 493 da Vinci systems during the quarter, compared to 415 systems a year earlier. This growth highlights the increasing adoption of its surgical solutions. Future Outlook Intuitive Surgical expects da Vinci procedures to grow by 13% to 16% in 2025. However, the company anticipates a 1 to 2 percentage point decline in its adjusted gross profit margin due to potential new tariffs, which could materially impact its financials. Technical Analysis Despite the strong earnings report, NASDAQ:ISRG shares fell by 2% in premarket trading. The stock’s overbought condition, indicated by an RSI of 75 as of Thursday’s close, suggests a potential for short-term correction. - Gap Down Pattern: Historically, gap-down patterns in NASDAQ:ISRG stock have been filled, hinting at a possible rebound in the coming sessions. This historical behavior aligns with the broader market’s tendency to correct temporary gaps. Key Support and Resistance Levels - Support: Immediate support lies at the 38.2% Fibonacci retracement level, which could act as a cushion in case of further price correction. - Resistance: The pivot point is situated above the 1-month high, presenting a significant barrier for upward momentum. Moving Averages The stock is trading above its 50-day, 100-day, and 200-day moving averages, underscoring its bullish trend in the medium to long term. This alignment of key moving averages strengthens the case for continued upside potential. Market Context - All-Time High: NASDAQ:ISRG shares closed at an all-time high on Thursday, marking a 62% gain over the past year. This performance underscores investor confidence in the company’s long-term prospects. - Sector Strength: The growing adoption of robotic surgical systems positions Intuitive Surgical as a leader in the medical device industry, benefiting from the broader trend toward minimally invasive procedures. Conclusion Intuitive Surgical’s robust financial results and operational milestones underscore its leadership in the surgical robotics market. While the current dip in premarket trading reflects short-term market dynamics, the stock’s strong technical indicators and historical performance suggest a potential rebound. Investors should monitor key support and resistance levels, along with updates on tariff developments, to assess the stock’s trajectory. With a bullish continuation pattern likely in play, NASDAQ:ISRG remains a compelling option for long-term growth-oriented investors.
NASDAQ:ISRGLong
by DEXWireNews
5-0 on Intuitive Surgical. ISRGHarmonic bullish 5-0 tentatively forming on ISRG. This is a pivot pattern that should bring kush, unless invalidated. And if it doesn't, you may even see a triple bottom in there if you try hard enough. We shall see how the events will unfold. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Confirmation level, where relevant, is a pink dotted, finite line. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe.
NASDAQ:ISRGLong
by Rykin_Capital
ISRG - MyMI Option PlaysSaw some worse-than-expected Quarterly Results and we were already looking at some Potential PUTs on the stock. We're looking at a potential $225 Price Target which we actually saw those price levels into today's premarket. We expect to see even lower price levels than $219 on a Double Oversold Bounce to the downside on the lower timeframes just due to the momentum to the downside. Could see some potential 100% gains intraday even, so will buy a few and then sell one to take the initial investment back and look at holding shares on the turnaround at the bottom. Will add lower time frame charts in comments on the trade! Thanks for tuning in! MyMI Wallet
NASDAQ:ISRGShort
by MyMIWallet
Intuitively dropping ISRG.Goals 254, 223. Invalidation 307. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe
NASDAQ:ISRGShort
by Rykin_Capital
ISRG consolidation then new highs or retest support?Just did a basic fib retracement on ISRG using that last low. Looks like the 50 fib line presents a consistent area of traffic and previous support. It tested the 236 fib area weeks ago and after managing to break through and hold, the stock made new highs. After failing to retest those highs at the end of the week, it settled back at the recent levels just shy of 950. That area has also been a short-term area of support. But does it hold these levels and bounce to retest ATH or is the retracement in effect heading back down closer to the 236 fib line? Have to see what comes with ISRG earnings during this next round. That 71.22% surprise last quarter didn't hurt but can it maintain the same pace now that things are beginning to normalize to some extent?
NASDAQ:ISRG
by PennyStocks101